PFIZER
Back to Income Statement
|
PFIZER Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
What is the latest Revenue of PFIZER ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,281 Cr |
| Mar2025 | ₹2,193 Cr |
| Mar2024 | ₹2,425 Cr |
| Mar2023 | ₹2,611 Cr |
| Mar2022 | ₹2,239 Cr |
How is Revenue of PFIZER Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,281 Cr | 4.02 | |
| Mar2025 | ₹2,193 Cr | -9.55 | |
| Mar2024 | ₹2,425 Cr | -7.13 | |
| Mar2023 | ₹2,611 Cr | 16.64 | |
| Mar2022 | ₹2,239 Cr | - | |
Compare Revenue of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,687.0 Cr | 2% | -0.1% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 2% |
-0.1% |
-20.4% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses